<DOC>
	<DOCNO>NCT02978196</DOCNO>
	<brief_summary>To evaluate efficacy safety 99m-Tc label anti-PD-L1 VHH SPECT/CT diagnostic image Non-Small Cell Lung Cancer compare exist gold standard `` biopsy PD-L1 detection '' . It also establish new method clinical diagnosis NSCLC use 99m-Tc label anti-PD-L1 VHH .</brief_summary>
	<brief_title>99m-Tc Labeled Anti-PD-L1 VHH Diagnostic Imaging Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Participant willing able give inform consent participation study protocolspecific screen procedure perform Male female , age 1875 year old Previous diagnosis nonsmall cell carcinoma , confirm pathology test AST , ALT , BUN , Cr double normal value Patients current history hepatitis A , hepatitis B , AIDS , tuberculosis infectious disease Severe infection PDL1 expression level undetermined Patients pacemaker Pregnant lactate woman Investigators professional decision subject participate clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>